Kyntra Bio, Inc. KYNB
$3.82
▼ -2.05%
($-0.08)
📉 Near 52W Low
⬇️ Below Yest. Low
🎈 Low Float
Open
$4.10
Prev Close
$3.90
Day Range
$3.50 – $4.11
52W Range
$3.60 – $11.39
Market Cap
$15.79M
P/E (TTM)
0.09
Beta
1.09
EPS (TTM)
$45.30
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-11-14 |
| Shares Out. | 4,050,000 |
| Website | kyntrabio.com/home ↗ |
| Phone | 14159781200 |
| Employees | 34 |
| Revenue | -$1.5M |
| Gross Profit | -$1.5M |
| Net Income | $12.0M |
| Free Cash Flow | -$38.1M |
| Total Assets | $101.1M |
| Total Liabilities | $109.2M |
| Equity | -$29.6M |
About Kyntra Bio, Inc.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Kyntra Bio, Inc. is a publicly traded company under the ticker symbol KYNB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-11-01)